S&P 500   3,941.26 (-1.44%)
DOW   33,596.34 (-1.03%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
S&P 500   3,941.26 (-1.44%)
DOW   33,596.34 (-1.03%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
S&P 500   3,941.26 (-1.44%)
DOW   33,596.34 (-1.03%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
S&P 500   3,941.26 (-1.44%)
DOW   33,596.34 (-1.03%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
OTCMKTS:CRGS

CurAegis Technologies - CRGS Stock Forecast, Price & News

$0.0001
0.00 (0.00%)
(As of 08/30/2022)
Add
Compare
Today's Range
$0.0001
▼
$0.0001
50-Day Range
N/A
52-Week Range
$0.0001
▼
$0.0040
Volume
5,900 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CRGS stock logo

About CurAegis Technologies (OTCMKTS:CRGS) Stock

CurAegis Technologies, Inc. does not have significant operations. Previously, it was engaged in the development and marketing of technologies in the areas of wellness, safety, and power. The company was formerly known as Torvec, Inc. and changed its name to CurAegis Technologies, Inc. in June 2016. CurAegis Technologies, Inc. was founded in 1996 and is based in Rochester, New York. On August 4, 2021, an involuntary petition for liquidation under Chapter 7 was filed against CurAegis Technologies, Inc. in the U.S. Bankruptcy Court for the Western District of New York. On August 31, 2021, the involuntary petition was approved by the Court.

Receive CRGS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CurAegis Technologies and its competitors with MarketBeat's FREE daily newsletter.

CRGS Stock News Headlines

May 28, 2020 | www.bloomberg.com
CurAegis Technologies, Inc. appoints Lance F. Drummond to Board of Directors
March 22, 2020 | www.barrons.com
CurAegis Technologies Inc.
November 2, 2019 | www.nasdaq.com
CurAegis Technologies (CRGS) Earnings Report Date
October 12, 2019 | markets.ft.com
CurAegis Technologies Inc
See More Headlines
Receive CRGS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CurAegis Technologies and its competitors with MarketBeat's FREE daily newsletter.

CRGS Company Calendar

Last Earnings
5/13/2020
Today
12/06/2022
Fiscal Year End
12/31/2022
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Motor vehicle parts & accessories
Sub-Industry
N/A
Sector
Business Services
Current Symbol
OTCMKTS:CRGS
Previous Symbol
OTCMKTS:TOVC
CUSIP
N/A
CIK
1063197
Web
www.curaegis.com
Phone
(585) 254-1100
Fax
585-254-1105
Employees
7
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$10,000.00
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. James R. Donnelly (Age 43)
    Pres, CEO, COO & Director
    Comp: $175k
  • Mr. Richard A. Kaplan (Age 76)
    Exec. Director
    Comp: $65k
  • Mr. Keith E. Gleasman (Age 75)
    Co-Founder & Independent Director
  • Mr. Jason Burke (Age 48)
    Chief Financial Officer
  • Mr. Richard B. Sullivan
    Corp. Counsel
  • Mr. Brandon Hudson
    Head of Product

Key Competitors

View All Competitors













CRGS Stock - Frequently Asked Questions

How have CRGS shares performed in 2022?

CurAegis Technologies' stock was trading at $0.0001 at the beginning of the year. Since then, CRGS shares have increased by 0.0% and is now trading at $0.0001.
View the best growth stocks for 2022 here.

How were CurAegis Technologies' earnings last quarter?

CurAegis Technologies, Inc. (OTCMKTS:CRGS) released its earnings results on Wednesday, May, 13th. The company reported ($0.02) EPS for the quarter.

What other stocks do shareholders of CurAegis Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CurAegis Technologies investors own include Allena Pharmaceuticals (ALNA), Arbutus Biopharma (ABUS), Matinas BioPharma (MTNB), Acasti Pharma (ACST), Aldeyra Therapeutics (ALDX), Ampio Pharmaceuticals (AMPE), Ampliphi Biosciences (APHB), BIOLASE (BIOL), Clearside Biomedical (CLSD) and LiveXLive Media (LIVX).

What is CurAegis Technologies' stock symbol?

CurAegis Technologies trades on the OTCMKTS under the ticker symbol "CRGS."

How do I buy shares of CurAegis Technologies?

Shares of CRGS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CurAegis Technologies' stock price today?

One share of CRGS stock can currently be purchased for approximately $0.00.

How can I contact CurAegis Technologies?

CurAegis Technologies' mailing address is 350 LINDEN OAKS, ROCHESTER NY, 14625. The official website for the company is www.curaegis.com. The company can be reached via phone at (585) 254-1100, via email at kbrowne@curaegis.com, or via fax at 585-254-1105.

This page (OTCMKTS:CRGS) was last updated on 12/6/2022 by MarketBeat.com Staff